• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺空洞作为新型冠状病毒肺炎的一种长期影像学表现

Lung Cavitation as a Long-Term Imaging Pattern of COVID-19.

作者信息

Çınar Caner, Kocakaya Derya, Olgun Yıldızeli Sehnaz, Karakurt Sait

机构信息

Pulmonology Department, Marmara University, Istanbul, TUR.

Pulmonology Department, Marmara University School of Medicine, Istanbul, TUR.

出版信息

Cureus. 2023 Jun 1;15(6):e39825. doi: 10.7759/cureus.39825. eCollection 2023 Jun.

DOI:10.7759/cureus.39825
PMID:37397682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10314721/
Abstract

Background A wide variety of radiological imaging findings, especially CT findings, have been reported in patients with COVID-19 pneumonia during the pandemic surge. Generally, on control chest imaging, individuals who have been cured of the disease usually show complete remission; however, in severe cases, residual pulmonary fibrosis, other abnormalities, and, rarely, lung cavitation can be observed. In this retrospective descriptive study, we aimed to describe the clinical, radiological, and laboratory characteristics of patients who developed lung cavitation in the course of SARS-CoV-2 disease recovery. Methodology Over a period of five months from March 1, 2021, to August 1, 2021, 15 consecutive patients who developed cavitary lesions on chest CT during the course of recovery from COVID-19 were recruited as the study population. All patients had a history of a SARS-CoV-2 infection diagnosed with a positive real-time polymerase chain reaction test. Patients who already had cavitary lesions in chest CT during the start of COVID-19 symptoms were excluded. Results In this study, 14 patients were male (93.3%). The only female patient was the only severely obese patient in the study population, with a body mass index was 40.4 kg/m. The median (range) age of the patient population was 61 (42-79) years. Eight patients (53.3%) required intensive care unit admission during the hospitalization period. Three patients who required intensive care unit were intubated and needed invasive mechanical ventilation. Two patients died during hospitalization. Conclusions Lung cavitation remains a rare occurrence in the course of COVID-19. Bronchoscopic evaluation and scanning for pulmonary embolism should be done in appropriate patients to determine secondary reasons for cavitation. Although this descriptive study showed that cavitary lesions can develop in patients with severe disease, more comprehensive studies with a control group are needed to reach a definitive conclusion.

摘要

背景 在新冠疫情高峰期,新冠肺炎患者出现了各种各样的放射影像学表现,尤其是CT表现。一般来说,在胸部影像学检查中,已治愈的患者通常显示完全缓解;然而,在严重病例中,可观察到残留肺纤维化、其他异常,以及罕见的肺空洞形成。在这项回顾性描述性研究中,我们旨在描述在新冠病毒疾病恢复过程中出现肺空洞的患者的临床、放射学和实验室特征。

方法 从2021年3月1日至2021年8月1日的五个月期间,连续招募了15例在新冠病毒感染康复过程中胸部CT出现空洞性病变的患者作为研究对象。所有患者均有实时聚合酶链反应检测呈阳性确诊的新冠病毒感染史。排除在新冠病毒感染症状开始时胸部CT就已存在空洞性病变的患者。

结果 在本研究中,14例患者为男性(93.3%)。唯一的女性患者是研究对象中唯一的重度肥胖患者,体重指数为40.4kg/m²。患者群体的年龄中位数(范围)为61(42-79)岁。8例患者(53.3%)在住院期间需要入住重症监护病房。3例需要重症监护的患者进行了气管插管,需要有创机械通气。2例患者在住院期间死亡。

结论 肺空洞在新冠病毒感染过程中仍然罕见。应对合适的患者进行支气管镜评估和肺栓塞扫描,以确定空洞形成的继发原因。尽管这项描述性研究表明重症患者可能出现空洞性病变,但需要进行更全面的有对照组的研究才能得出明确结论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85a/10314721/2541a7086937/cureus-0015-00000039825-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85a/10314721/2541a7086937/cureus-0015-00000039825-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85a/10314721/2541a7086937/cureus-0015-00000039825-i01.jpg

相似文献

1
Lung Cavitation as a Long-Term Imaging Pattern of COVID-19.肺空洞作为新型冠状病毒肺炎的一种长期影像学表现
Cureus. 2023 Jun 1;15(6):e39825. doi: 10.7759/cureus.39825. eCollection 2023 Jun.
2
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
3
Pulmonary cavitation: an under-recognized late complication of severe COVID-19 lung disease.肺部空洞:严重 COVID-19 肺部疾病的一种被低估的晚期并发症。
BMC Pulm Med. 2021 Jan 12;21(1):24. doi: 10.1186/s12890-020-01379-1.
4
[Cavitary lung lesions in COVID-19 associated pneumonia: a single-center study of 40 cases].[新型冠状病毒肺炎相关肺炎的肺空洞病变:一项40例单中心研究]
Khirurgiia (Mosk). 2024(6):28-35. doi: 10.17116/hirurgia202406128.
5
Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.重症监护治疗新型冠状病毒 SARS-CoV-2 感染患者:意大利克雷马医院的经验。
Am J Emerg Med. 2021 Jul;45:156-161. doi: 10.1016/j.ajem.2020.08.005. Epub 2020 Aug 16.
6
Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective Cohort.新冠肺炎危重症幸存者的肺功能和影像学特征:一项为期 3 个月的前瞻性队列研究。
Chest. 2021 Jul;160(1):187-198. doi: 10.1016/j.chest.2021.02.062. Epub 2021 Mar 4.
7
Evidence for a thromboembolic pathogenesis of lung cavitations in severely ill COVID-19 patients.严重 COVID-19 患者肺部空洞形成的血栓栓塞发病机制的证据。
Sci Rep. 2021 Aug 6;11(1):16039. doi: 10.1038/s41598-021-95694-0.
8
A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.一项评估静脉注射瑞维鲁单抗对比 COVID-19 重症肺炎、急性肺损伤或急性呼吸窘迫综合征患者最佳支持治疗的疗效和安全性的 III 期开放性标签、随机对照研究:一项随机对照试验研究方案的结构性总结。
Trials. 2020 Jul 13;21(1):639. doi: 10.1186/s13063-020-04548-z.
9
Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.住院 COVID-19 患者的凝血病:治疗性抗凝与标准治疗作为对 COVID-19 大流行的快速反应的实用随机对照试验 (RAPID COVID COAG - RAPID 试验):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Mar 10;22(1):202. doi: 10.1186/s13063-021-05076-0.
10
Temporal changes of lung computed tomography findings pulmonary COVID-19 infection.肺部 COVID-19 感染的肺部计算机断层扫描结果的时间变化。
J Med Imaging Radiat Sci. 2022 Dec;53(4):564-570. doi: 10.1016/j.jmir.2022.09.024. Epub 2022 Oct 23.

本文引用的文献

1
Body Mass Index and Risk for COVID-19-Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death - United States, March-December 2020.体重指数与 2020 年 3 月至 12 月期间 COVID-19 相关住院、重症监护病房收治、有创机械通气和死亡风险的关系-美国。
MMWR Morb Mortal Wkly Rep. 2021 Mar 12;70(10):355-361. doi: 10.15585/mmwr.mm7010e4.
2
Lymphopenia as a Biological Predictor of Outcomes in COVID-19 Patients: A Nationwide Cohort Study.淋巴细胞减少作为COVID-19患者预后的生物学预测指标:一项全国性队列研究。
Cancers (Basel). 2021 Jan 26;13(3):471. doi: 10.3390/cancers13030471.
3
Men and COVID-19: A Pathophysiologic Review.
男性与 COVID-19:病理生理学综述。
Am J Mens Health. 2020 Sep-Oct;14(5):1557988320954021. doi: 10.1177/1557988320954021.
4
A minimal common outcome measure set for COVID-19 clinical research.用于 COVID-19 临床研究的最小通用结局指标集。
Lancet Infect Dis. 2020 Aug;20(8):e192-e197. doi: 10.1016/S1473-3099(20)30483-7. Epub 2020 Jun 12.
5
Large pulmonary cavity in COVID-19 cured patient case report.COVID-19 治愈患者大肺空洞病例报告。
Ann Palliat Med. 2021 May;10(5):5786-5791. doi: 10.21037/apm-20-452. Epub 2020 Jun 9.
6
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.严重严重急性呼吸综合征冠状病毒 2 型感染患者的血栓形成风险高:一项多中心前瞻性队列研究。
Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.
7
Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction.对新冠病毒疾病(COVID-19)患者的尸检显示,肺部出现弥漫性肺泡损伤,伴有严重的毛细血管充血,肺部及其他器官呈现出多样化的表现,提示存在血管功能障碍。
Histopathology. 2020 Aug;77(2):198-209. doi: 10.1111/his.14134. Epub 2020 Jul 5.
8
Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA - Secondary Publication.北美放射学会关于报告与 COVID-19 相关的胸部 CT 结果的专家共识声明。得到胸放射学会、美国放射学会和 RSNA 的认可 - 二次出版物。
J Thorac Imaging. 2020 Jul;35(4):219-227. doi: 10.1097/RTI.0000000000000524.
9
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.中性粒细胞与淋巴细胞比值可作为 COVID-19 住院患者死亡的独立危险因素。
J Infect. 2020 Jul;81(1):e6-e12. doi: 10.1016/j.jinf.2020.04.002. Epub 2020 Apr 10.
10
Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19.COVID-19 阳性患者的胸部 X 线表现的频率和分布。
Radiology. 2020 Aug;296(2):E72-E78. doi: 10.1148/radiol.2020201160. Epub 2020 Mar 27.